Loncastuximab Tesirine in Previously Treated Diffuse Lare B-Cell Lymphoma
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Loncastuximab Tesirine in Previously Treated Diffuse Lare B-Cell Lymphoma

Sponsor: ADC Therapeutics

Protocol ADCT-402-201 is a trial evaluating the efficacy and safety of Loncastuximab Tesirine in patients with diffuse large b-cell lymphoma that have previously been treated with at least two multi-agent treatment regimens.